Patent details

EP3417294 Title: METHODS COMPRISING FIXED INTERMITTENT DOSING OF CEDIRANIB

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP3417294
WO Application Number:
US2017017804
Type:
European Patent Granted for NL
Status:
Patent in Force
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP17753704.0
WO Publication Number:
WO2017142871
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
Sweden (SE)
Publications:

Dates

Filing date:
14/02/2017
Grant date:
01/12/2021
EP Publication Date:
26/12/2018
WO Publication Date:
24/08/2017
Claims Translations Received Date:
Claims Translation B1 Received Date:
16/02/2022
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
01/12/2021
EP B1 Publication Date:
01/12/2021
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
13/02/2037
Lapsed By Expiration Date:
Patent Validated Date:
02/03/2022
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
16/05/2022
 
 

 

Name:
The United States of America, as Represented By the Secretary, Department of Health and Human Services
Address:
Office of Technology Transfer 6701 Rocklegde Drive Suite 700, MSC 7788, 20892, Bethesda, MD, United States of America (US)

From:
01/12/2021
 
 

 

Name:
Astrazeneca AB
Address:
151 85 Södertälje, Sweden (SE)

Historical Applicant/holder

From:
01/12/2021
To:
16/05/2022

 

Name:
The United States of America, as Represented By the Secretary, Department of Health and Human Services
Address:
Office of Technology Transfer National Institutes of Health 6011 Executive Boulevard Suite 325 MSC 7660, Bethesda, MD 20892-7660, United States of America (US)

Agent

Name:
ir. W.J.J.M. Kempes
From:
01/03/2022
Address:
Dogio Patents Postbus 2350, 1200 CJ, Hilversum, Netherlands (NL)
To:

Inventor

1

Name:
BARRY, Simon
Address:
Cambridge CB4 0WG, United Kingdom (GB)

2

Name:
KENDREW, Jane
Address:
Macclesfield Cheshire SK10 4TG, United Kingdom (GB)

3

Name:
HO, Tony
Address:
Gaithersburg, MD 20878, United States of America (US)

4

Name:
WEDGE, Stephen, Robert
Address:
Granta Park Cambridge CB21 6GH, United Kingdom (GB)

5

Name:
IVY,Susan Percy
Address:
Bethesda, MD 20892-7660, United States of America (US)

6

Name:
KOHN, Elise
Address:
Bethesda, MD 20892-7660, United States of America (US)

7

Name:
LEE, Jung-Min
Address:
Bethesda, MD 20892-7660, United States of America (US)

Priority

Priority Patent Number:
201662295421 P
Priority Date:
15/02/2016
Priority Country:
United States of America (US)

Classification

IPC or IDT classification:
C07K 16/28; G01N 33/574; A61K 38/00; A61P 35/00; A61K 31/502; A61K 31/506; A61K 45/06; A61K 48/00; A61P 9/10; A61P 43/00; A61K 39/395;

Publication

Bulletin

1

Bulletin Heading:
EP3
Journal edition number:
09/22
Publication date:
02/03/2022
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

2

Bulletin Heading:
EP2
Journal edition number:
48/21
Publication date:
01/12/2021
Description:
European patents granted for the Netherlands

European Patent Bulletin

1

Issue number:
202218
Publication date:
04/05/2022
Description:
Document reprinted after correction (B8, B9)

2

Issue number:
202201
Publication date:
05/01/2022
Description:
Application number/publication number of the divisional application (Art. 76) changed

3

Issue number:
202148
Publication date:
01/12/2021
Description:
Grant (B1)

Deed

Change of Address

Change Kind/ Decision Type:
Owner
Deed Number:
RC202201252A
Date Registered:
16/05/2022
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
Rws Group, Translation Division
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Annual Fee

Annual Fee(s) Due Date:
28/02/2026
Annual Fee Number:
10
Annual Fee Amount:
400 Euro
Last Annual Payment Date:
21/01/2025
Last Annual Fee Paid Number:
9
Last Annual Fee Paid Amount:
340 Euro
Payer:
Anaqua Services
Filing date Document type Document Description Number of pages File Type
01/03/2022 Outgoing Correspondence Letter no formal defects 2 PDF /7/7/8/8/4/0800748877/docs/ep17753704.0_0_465441l271.pdf
16/02/2022 Claims First filed claims 2 PDF /7/7/8/8/4/0800748877/docs/ep17753704.0_1_claims20220216184510079.pdf